JPMorgan Chase & Co. Lowers Tempus AI (NASDAQ:TEM) Price Target to $80.00

Tempus AI (NASDAQ:TEM) had its price objective dropped by investment analysts at JPMorgan Chase & Co. from $85.00 to $80.00 in a research note issued on Monday,Benzinga reports. The firm presently has a “neutral” rating on the stock. JPMorgan Chase & Co.‘s target price would suggest a potential upside of 17.46% from the stock’s current price.

A number of other equities research analysts have also recently issued reports on the stock. Weiss Ratings reissued a “sell (d-)” rating on shares of Tempus AI in a research note on Wednesday, October 8th. TD Cowen lowered shares of Tempus AI from a “buy” rating to a “hold” rating and set a $88.00 target price on the stock. in a research report on Tuesday, October 21st. Canaccord Genuity Group cut their target price on shares of Tempus AI from $110.00 to $95.00 and set a “buy” rating for the company in a research note on Wednesday, November 5th. HC Wainwright reduced their price target on shares of Tempus AI from $98.00 to $89.00 and set a “buy” rating for the company in a research report on Friday, November 7th. Finally, Needham & Company LLC raised their price target on shares of Tempus AI from $70.00 to $100.00 and gave the company a “buy” rating in a research note on Wednesday, November 5th. Seven investment analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat, Tempus AI presently has a consensus rating of “Hold” and an average target price of $85.36.

Tempus AI Stock Performance

NASDAQ TEM opened at $68.11 on Monday. The stock has a market capitalization of $12.12 billion, a price-to-earnings ratio of -57.23 and a beta of 4.99. Tempus AI has a twelve month low of $31.36 and a twelve month high of $104.32. The company has a current ratio of 3.28, a quick ratio of 3.12 and a debt-to-equity ratio of 2.45. The stock has a 50-day moving average of $79.98 and a 200 day moving average of $73.79.

Tempus AI (NASDAQ:TEM) last issued its quarterly earnings data on Tuesday, November 4th. The company reported ($0.11) EPS for the quarter, beating the consensus estimate of ($0.16) by $0.05. The company had revenue of $334.21 million for the quarter, compared to analyst estimates of $328.89 million. Tempus AI had a negative return on equity of 73.21% and a negative net margin of 18.45%.Tempus AI’s quarterly revenue was up 84.7% compared to the same quarter last year. During the same period last year, the company earned ($0.46) earnings per share. Sell-side analysts anticipate that Tempus AI will post -6.15 EPS for the current fiscal year.

Insider Buying and Selling at Tempus AI

In other Tempus AI news, CFO James William Rogers sold 19,966 shares of the business’s stock in a transaction on Thursday, December 11th. The stock was sold at an average price of $73.20, for a total transaction of $1,461,511.20. Following the transaction, the chief financial officer owned 111,250 shares of the company’s stock, valued at approximately $8,143,500. The trade was a 15.22% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, EVP Andrew Polovin sold 12,874 shares of the company’s stock in a transaction on Monday, November 24th. The shares were sold at an average price of $75.00, for a total value of $965,550.00. Following the completion of the sale, the executive vice president owned 107,590 shares of the company’s stock, valued at approximately $8,069,250. The trade was a 10.69% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. In the last three months, insiders sold 1,097,780 shares of company stock valued at $86,054,406. Corporate insiders own 26.27% of the company’s stock.

Institutional Investors Weigh In On Tempus AI

Several hedge funds and other institutional investors have recently added to or reduced their stakes in TEM. Cranbrook Wealth Management LLC acquired a new position in Tempus AI during the 3rd quarter worth about $25,000. Concord Wealth Partners grew its position in Tempus AI by 308.0% in the 2nd quarter. Concord Wealth Partners now owns 408 shares of the company’s stock valued at $26,000 after acquiring an additional 308 shares in the last quarter. JPL Wealth Management LLC purchased a new stake in Tempus AI during the third quarter worth about $26,000. GAMMA Investing LLC purchased a new stake in Tempus AI during the third quarter worth about $28,000. Finally, Allworth Financial LP lifted its position in shares of Tempus AI by 5,000.0% during the second quarter. Allworth Financial LP now owns 459 shares of the company’s stock worth $29,000 after purchasing an additional 450 shares in the last quarter. Institutional investors and hedge funds own 24.22% of the company’s stock.

About Tempus AI

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.